Last reviewed · How we verify
NCT05701410: CASS-I
Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.
NA trial testing DPD scintigraphy in Cardiac Amyloidosis in 200 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Steen Hvitfeldt Poulsen |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 200 |
| Start date | 1 January 2023 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 April 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- DPD scintigraphy
Conditions studied
- Cardiac Amyloidosis — all drugs for Cardiac Amyloidosis →
- Spinal Stenosis — all drugs for Spinal Stenosis →
Sponsor
Steen Hvitfeldt Poulsen — full company profile →
Who can join
60 and older, any sex, with Cardiac Amyloidosis or Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study investigates the prevalence of cardiac amyloidosis among patients with a history of lumbar spinal stenosis within the last ten years in the region of central Denmark.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05701410
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of DPD scintigraphy
Trials testing the same drug.
- NCT05701397 — Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis. · NA · unknown
Other recruiting trials for Cardiac Amyloidosis
Currently open trials in the same condition.
- NCT07232459 — [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis · recruiting
- NCT06788535 — Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis · Phase 3 · active not recruiting
- NCT06458374 — ATTR Cardiac Amyloidosis in a Selected Population · recruiting
- NCT06427304 — Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure · recruiting
- NCT06907836 — Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine · recruiting
Other Steen Hvitfeldt Poulsen trials
Trials by the same sponsor.
- NCT06372301 — Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy · NA · recruiting
- NCT05701397 — Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis. · NA · unknown
- NCT05699044 — Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation · unknown
- NCT05633563 — The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Dia · Phase 4 · completed
- NCT04276220 — Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05701410 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Steen Hvitfeldt Poulsen
- Last refreshed: 27 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05701410.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing